A timely reminder about an evolving clinical entity: nephrogenic systemic fibrosis and gadolinium use in CKD.
Jamboti
Jagadish
J
D003287:Contrast Media / Q000009:adverse effects*; D005355:Fibrosis / Q000139:chemically induced* / Q000473:pathology; D005682:Gadolinium / Q000009:adverse effects*; D005919:Glomerular Filtration Rate; D006207:Half-Life; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D007676:Kidney Failure, Chronic / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging / Q000009:adverse effects
D003287:Contrast Media; D005682:Gadolinium